Table of Contents

2019-2024 Global Epinephrine Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Epinephrine Consumption 2014-2024
  • 2.1.2 Epinephrine Consumption CAGR by Region
• 2.2 Epinephrine Segment by Type
  • 2.2.1 Epinephrine Auto-injector
  • 2.2.2 Epinephrine Prefilled Syringe
  • 2.2.3 Combination Epinephrine Products
• 2.3 Epinephrine Consumption by Type
  • 2.3.1 Global Epinephrine Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Epinephrine Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Epinephrine Sale Price by Type (2014-2019)
• 2.4 Epinephrine Segment by Application
  • 2.4.1 Anaphylaxis
  • 2.4.2 Cardiac Arrest
  • 2.4.3 Others
• 2.5 Epinephrine Consumption by Application
  • 2.5.1 Global Epinephrine Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Epinephrine Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Epinephrine Sale Price by Application (2014-2019)

3 Global Epinephrine by Players

• 3.1 Global Epinephrine Sales Market Share by Players
  • 3.1.1 Global Epinephrine Sales by Players (2017-2019)
  • 3.1.2 Global Epinephrine Sales Market Share by Players (2017-2019)
• 3.2 Global Epinephrine Revenue Market Share by Players
  • 3.2.1 Global Epinephrine Revenue by Players (2017-2019)
  • 3.2.2 Global Epinephrine Revenue Market Share by Players (2017-2019)
• 3.3 Global Epinephrine Sale Price by Players
• 3.4 Global Epinephrine Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Epinephrine Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Epinephrine Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Epinephrine by Regions

• 4.1 Epinephrine by Regions
  • 4.1.1 Global Epinephrine Consumption by Regions
  • 4.1.2 Global Epinephrine Value by Regions
• 4.2 Americas Epinephrine Consumption Growth
• 4.3 APAC Epinephrine Consumption Growth
• 4.4 Europe Epinephrine Consumption Growth
• 4.5 Middle East & Africa Epinephrine Consumption Growth

5 Americas

• 5.1 Americas Epinephrine Consumption by Countries
  • 5.1.1 Americas Epinephrine Consumption by Countries (2014-2019)
  • 5.1.2 Americas Epinephrine Value by Countries (2014-2019)
• 5.2 Americas Epinephrine Consumption by Type
• 5.3 Americas Epinephrine Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Epinephrine Consumption by Countries
  • 6.1.1 APAC Epinephrine Consumption by Countries (2014-2019)
  • 6.1.2 APAC Epinephrine Value by Countries (2014-2019)
• 6.2 APAC Epinephrine Consumption by Type
• 6.3 APAC Epinephrine Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Epinephrine by Countries
  • 7.1.1 Europe Epinephrine Consumption by Countries (2014-2019)
  • 7.1.2 Europe Epinephrine Value by Countries (2014-2019)
• 7.2 Europe Epinephrine Consumption by Type
• 7.3 Europe Epinephrine Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Epinephrine by Countries
  • 8.1.1 Middle East & Africa Epinephrine Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Epinephrine Value by Countries (2014-2019)
• 8.2 Middle East & Africa Epinephrine Consumption by Type
• 8.3 Middle East & Africa Epinephrine Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Epinephrine Distributors
• 10.3 Epinephrine Customer

11 Global Epinephrine Market Forecast

• 11.1 Global Epinephrine Consumption Forecast (2019-2024)
• 11.2 Global Epinephrine Forecast by Regions
  • 11.2.1 Global Epinephrine Forecast by Regions (2019-2024)
  • 11.2.2 Global Epinephrine Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Epinephrine Forecast by Type
• 11.8 Global Epinephrine Forecast by Application

12 Key Players Analysis

• 12.1 Mylan Inc
  • 12.1.1 Company Details
  • 12.1.2 Epinephrine Product Offered
  • 12.1.3 Mylan Inc Epinephrine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Mylan Inc News
• 12.2 Impax
  • 12.2.1 Company Details
  • 12.2.2 Epinephrine Product Offered
  • 12.2.3 Impax Epinephrine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Impax News
• 12.3 ALK Abello
  • 12.3.1 Company Details
  • 12.3.2 Epinephrine Product Offered
  • 12.3.3 ALK Abello Epinephrine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 ALK Abello News
• 12.4 Lincoln Medical Ltd
  • 12.4.1 Company Details
  • 12.4.2 Epinephrine Product Offered
  • 12.4.3 Lincoln Medical Ltd Epinephrine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Lincoln Medical Ltd News
• 12.5 Pfizer
  • 12.5.1 Company Details
  • 12.5.2 Epinephrine Product Offered
  • 12.5.3 Pfizer Epinephrine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Pfizer News
• 12.6 Amphastar
  • 12.6.1 Company Details
  • 12.6.2 Epinephrine Product Offered
  • 12.6.3 Amphastar Epinephrine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Amphastar News
• 12.7 Emerade
  • 12.7.1 Company Details
  • 12.7.2 Epinephrine Product Offered
  • 12.7.3 Emerade Epinephrine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Emerade News
• 12.8 Grand Pharma
  • 12.8.1 Company Details
  • 12.8.2 Epinephrine Product Offered
  • 12.8.3 Grand Pharma Epinephrine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Grand Pharma News
• 12.9 Harvest Pharmaceuticals
  • 12.9.1 Company Details
  • 12.9.2 Epinephrine Product Offered
  • 12.9.3 Harvest Pharmaceuticals Epinephrine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Harvest Pharmaceuticals News
• 12.10 Merit Pharmaceutical
  • 12.10.1 Company Details
  • 12.10.2 Epinephrine Product Offered
  • 12.10.3 Merit Pharmaceutical Epinephrine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Merit Pharmaceutical News
• 12.11 Tianjin Jinyao Group

13 Research Findings and Conclusion

Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.
United States has the largest global export quantity and manufacturers in Epinephrine market, while the Europe is the second sales volume market for Epinephrine in 2017.

In the industry, Mylan Inc profits most in 2016 and recent years, while Impax and ALK Abello ranked 2 and 3.The market share of them is 52.75%, 4.37% and 2.64% in 2017.The gap of market share is keep on enlarged due to different strategy.

Nowadays, there are three mainly types of Epinephrine, including Epinephrine Auto-injector, Epinephrine Prefilled Syringe and Combination Epinephrine Products. And Epinephrine Auto-injector is the main type for Epinephrine, and the Epinephrine Auto-injector reached a sales value of approximately 1430.61 M USD in 2017, with 63.69% of global sales value.

Epinephrine technology is much mature now, and new enterprises can not surpass existing famous brands on reputation or design in the short term. So, the study group recommends the new entrants need to be considered carefully before enter into this field.

According to this study, over the next five years the Epinephrine market will register a 7.2% CAGR in terms of revenue, the global market size will reach US$ 3410 million by 2024, from US$ 2250 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Epinephrine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Epinephrine market by product type, application, key manufacturers and key regions and countries.

This study considers the Epinephrine value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Epinephrine Auto-injector
Epinephrine Prefilled Syringe
Combination Epinephrine Products
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Anaphylaxis
Cardiac Arrest
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Mylan Inc
Impax
ALK Abello
Lincoln Medical Ltd
Pfizer
Amphastar
Emerade
Grand Pharma
Harvest Pharmaceuticals
Merit Pharmaceutical
Tianjin Jinyao Group

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Epinephrine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Epinephrine market by identifying its various subsegments.
Focuses on the key global Epinephrine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Epinephrine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Epinephrine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.